[PPAR agonists: elixir of eternal youth for the kidney?].
Grosjean
Fabrizio
F
Div. of Experimental Diabetes and Aging, Mount Sinai Medical School, New York, USA. fabrizio.grosjean@gmail.com
D000375:Aging / Q000187:drug effects; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000378:metabolism; D019317:Evidence-Based Medicine; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007668:Kidney / Q000098:blood supply* / Q000378:metabolism; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism*; D008928:Mitochondria / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists*
D000975:Antioxidants; D007004:Hypoglycemic Agents; D047492:Peroxisome Proliferator-Activated Receptors